These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 10321437)

  • 21. Moderate alcohol consumption and coronary heart disease: a review.
    Hines LM; Rimm EB
    Postgrad Med J; 2001 Dec; 77(914):747-52. PubMed ID: 11723311
    [No Abstract]   [Full Text] [Related]  

  • 22. Hyperlipidaemia and cardiovascular disease.
    Sussekov AV
    Curr Opin Lipidol; 1999 Dec; 10(6):635-9. PubMed ID: 10680059
    [No Abstract]   [Full Text] [Related]  

  • 23. [Prevention of coronary disease in clinical practice. Guidelines of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension].
    Pyorala K; De Backer G; Graham I; Poole-wilson P; Wood D
    G Ital Cardiol; 1996 Feb; 26(2):127-68. PubMed ID: 8666173
    [No Abstract]   [Full Text] [Related]  

  • 24. [Prevention of coronary disease in clinical practice. Recommendations of the Task-Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension].
    Pyörälä K; de Backer G; Graham I; Poole-Wilson P; Wood D
    Ann Cardiol Angeiol (Paris); 1995 Sep; 44(7):379-88. PubMed ID: 8561444
    [No Abstract]   [Full Text] [Related]  

  • 25. Evaluating coronary heart disease risk. Tiles in the mosaic.
    Hoeg JM
    JAMA; 1997 May; 277(17):1387-90. PubMed ID: 9134945
    [No Abstract]   [Full Text] [Related]  

  • 26. Report of Inter-Society Commission for Heart Disease Resources. Prevention of Cardiovascular Disease. Primary prevention of the atherosclerotic diseases.
    Circulation; 1970 Dec; 42(6):A55-95. PubMed ID: 5492550
    [No Abstract]   [Full Text] [Related]  

  • 27. Prevention of coronary heart disease in clinical practice. Recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension.
    Pyörälä K; De Backer G; Graham I; Poole-Wilson P; Wood D
    Eur Heart J; 1994 Oct; 15(10):1300-31. PubMed ID: 7821306
    [No Abstract]   [Full Text] [Related]  

  • 28. Prevention of coronary heart disease in clinical practice: recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension.
    Pyörälä K; De Backer G; Graham I; Poole-Wilson P; Wood D
    Atherosclerosis; 1994 Oct; 110(2):121-61. PubMed ID: 7848365
    [No Abstract]   [Full Text] [Related]  

  • 29. Primary prevention of coronary heart disease: integrating risk assessment with intervention.
    Grundy SM
    Circulation; 1999 Aug; 100(9):988-98. PubMed ID: 10468531
    [No Abstract]   [Full Text] [Related]  

  • 30. [Nutrition in disorders of lipid metabolism].
    Oster P; Arab L; Kohlmeier M; Mordasini R; Schellenberg B; Schlierf G
    Wien Med Wochenschr; 1982 Mar; 132(5):97-100. PubMed ID: 7080508
    [No Abstract]   [Full Text] [Related]  

  • 31. [Prevention of arteriosclerosis in Italy].
    Ricci G
    Clin Ter; 1984 Oct; 111(1):9-13. PubMed ID: 6238783
    [No Abstract]   [Full Text] [Related]  

  • 32. Secondary prevention of coronary heart disease in clinical practice: special considerations for intensified lifestyle modification.
    Martínez-Rubio A
    Eur J Clin Invest; 1999 May; 29(5):365-8. PubMed ID: 10354191
    [No Abstract]   [Full Text] [Related]  

  • 33. Effects of antihypertensive therapy on glucose and lipid metabolism.
    Zehetgruber M; Christ G; Mundigler G; Gabriel H; Huber K
    Wien Klin Wochenschr; 1996 Dec; 108(24):775-80. PubMed ID: 9017889
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vascular disease and lipids in diabetes.
    Garber AJ
    Med Clin North Am; 1998 Jul; 82(4):931-48. PubMed ID: 9706127
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Current thinking: to force stored cholesterol to leave the vascular wall].
    Osterberg S
    Lakartidningen; 1976 Aug; 73(35):2827-8. PubMed ID: 966850
    [No Abstract]   [Full Text] [Related]  

  • 36. Committee report: childhood diet and prevention of coronary heart disease. ESPGAN Committee on Nutrition. European Society of Pediatric Gastroenterology and Nutrition.
    Aggett PJ; Haschke F; Heine W; Hernell O; Koletzko B; Lafeber H; Ormission A; Rey J; Tormo R
    J Pediatr Gastroenterol Nutr; 1994 Oct; 19(3):261-9. PubMed ID: 7815255
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 3-Hydroxy-3-methylglutaryl coenzyme a (HMG-CoA) reductase inhibitors (statins), atherosclerosis and coronary syndromes.
    Blum A; Simsolo C; Hasin Y
    Atherosclerosis; 2004 Jul; 175(1):1-5. PubMed ID: 15186940
    [No Abstract]   [Full Text] [Related]  

  • 38. [Prevention of coronary diseases in daily clinical practice].
    Degré S
    Rev Med Brux; 1996 Sep; 17(4):181-4. PubMed ID: 8927842
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effectiveness and efficiency of different guidelines on statin treatment for preventing deaths from coronary heart disease: modelling study.
    Manuel DG; Kwong K; Tanuseputro P; Lim J; Mustard CA; Anderson GM; Ardal S; Alter DA; Laupacis A
    BMJ; 2006 Jun; 332(7555):1419. PubMed ID: 16737980
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Statins in primary prevention of coronary heart disease].
    Paulweber B
    Wien Med Wochenschr; 1999; 149(5-6):129-38. PubMed ID: 10408004
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.